INTRODUCTION {#SEC1}
============

First identified and characterized as a DNA modification in bacteria, N^6^-adenine methylation (6mA) was for a long time only known in a few eukaryotes, including the ciliate *Tetrahymena thermophila* ([@B1]). More recently, 6mA has been identified in the genomic DNA of a wide range of eukaryotic organisms, from protists and basal fungi ([@B5]) to animals and plants ([@B8]). Nevertheless, DNA 6mA is far from universal in eukaryotes. Furthermore, in animals such as worms, flies, mice, and humans ([@B11],[@B12],[@B14],[@B15],[@B18]), 6mA levels are orders of magnitude lower than those in unicellular eukaryotes such as *Tetrahymena* ([@B1],[@B19]) and *Chlamydomonas* ([@B6]). Even more complicated are the functions of 6mA. It is implicated as an epigenetic mark for either transcription activation or repression, depending on the organism under study ([@B6],[@B10],[@B13],[@B14],[@B17]). It is also reported to regulate development in the fly ([@B16]), carry heritable epigenetic information in the worm ([@B8],[@B20]), respond dynamically to stress in the mouse brain ([@B21]), and participate in carcinogenesis of human glioblastoma ([@B15],[@B18]). The patchy distribution, varying abundance, and divergent functions of DNA 6mA in eukaryotes suggest a complex evolutionary history.

Comprehensive phylogenomic analyses guide the search for DNA 6mA methyltransferases (MTases) in eukaryotes. Prominent among potential candidates are members of the MT-A70 family, which evolved from the bacterial M.MunI-like DNA 6mA MTase ([@B22]). Eukaryotic MT-A70 family members METTL3 and METTL14 form a heterodimer and deposit m6A in mRNA---facilitated by the single-stranded RNA binding CCCH domain of METTL3 ([@B23]). It is extrapolated that the MT-A70 MTase domain, tethered to structural domains with an alternative substrate preference, may catalyze DNA 6mA. Indeed, recent studies support that METTL4 orthologues, representing a separate subclade of the eukaryotic MT-A70 family widespread in animals and plants, are likely DNA 6mA MTases ([@B8]). Still, other subclades of the eukaryotic MT-A70 family---each with their own distinct domain architectures---are poorly studied. Their functional analyses promise to reveal the molecular mechanisms underpinning divergent 6mA behaviors and substantiate their independent origins.

DNA 6mA in *Tetrahymena*, discovered \>40 years ago ([@B1]), is highly abundant (∼1% of adenine). It is enriched in linker DNA of stereotypical nucleosome arrays downstream of transcription start sites, as an integral part of the epigenetic landscape ([@B1],[@B19],[@B24],[@B25]). These findings strongly suggest that DNA 6mA in *Tetrahymena* is deposited by specific MTases rather than by random uncatalyzed reactions. As putative DNA 6mA MTases, there are several MT-A70 family members in the *Tetrahymena* genome (Figure [1](#F1){ref-type="fig"}). Here, we identify AMT1 (adenine methyltransferase 1), belonging to a distinct and previously uncharacterized eukaryotic MT-A70 subclade, as the one required for the bulk DNA 6mA in general, and for symmetric ApT methylation in particular. We also provide detailed functional analysis of AMT1-dependent 6mA, supporting its role for regulating cell growth and development, as an active epigenetic mark associated with RNA polymerase II (Pol II) transcription. Despite their absence in animals, plants and true fungi, AMT1 orthologues are present in all the eukaryotic super-groups. Their phylogenetic distribution coincides with abundant 6mA in genomic DNA, especially symmetric ApT methylation, supporting AMT1 homologues as prototypical DNA 6mA MTases in eukaryotes.

![Phylogenetic analysis and domain structure comparison of AMTs 1--7. (**A**) Phylogenetic analysis of MT-A70 proteins. DNA 6mA (subclades AMT2/5, AMT1, METTL4/DAMT1 and AMT6/7) and RNA m6A (subclades METTL3 and METTL14) methyltransferase candidates are separated by a dotted line. Species are marked by different colors based on their phylogenetic position in the eukaryotic tree (inset). AMTs 1--7 of *Tetrahymena* are in bold plus red. The scale bar corresponds to 1 expected amino acid substitution per site. See [Supplementary Table S9](#sup1){ref-type="supplementary-material"} for details (species full name and NCBI GI number). (**B**) Conserved domains and motifs in AMTs 1--7. Gene names used in Luo *et al.* ([@B70]) and Beh *et al.* ([@B75]) are shown in parentheses. MT-A70 domains of AMTs 1--5 were predicted by CD-Search ([@B69]), while domain structures of AMT6 and AMT7 were inferred from sequence alignment with AMTs 1--5.](gkz1053fig1){#F1}

MATERIALS AND METHODS {#SEC2}
=====================

Cell culture {#SEC2-1}
------------

*Tetrahymena thermophila* wild-type strains (SB210 and CU428) were obtained from the *Tetrahymena* Stock Center (<http://tetrahymena.vet.cornell.edu>). Δ*AMT1* was a homozygous homokaryon strain generated in this study. Cells were grown in SPP medium at 30°C ([@B26],[@B27]).

Generation of *Tetrahymena* strains {#SEC2-2}
-----------------------------------

To generate the Δ*AMT1* construct, the *neo4* cassette ([@B28],[@B90]) was flanked with the 5′ and 3′ flanking regions of *AMT1* (TTHERM_00704040) ([Supplementary Figure S1A, B and Table S8](#sup1){ref-type="supplementary-material"}). Starved WT cells of two different mating types (SB210 and CU428) were mated and transformed with the Δ*AMT1* construct at 3 h post-mixing. Homozygous heterokaryon strains that were *AMT1* knockout in the MIC, while retaining the intact *AMT1* gene in the MAC, were generated by germline transformation and standard genetic manipulations ([@B29],[@B30]). By crossing two homozygous heterokaryon strains, homozygous homokaryon strains (Δ*AMT1* cells) were generated that are *AMT1* knockout in both the MIC and MAC. This was confirmed by the SMRT sequencing and by the amplification of the *AMT1* transcript using RT-PCR ([Supplementary Figure S1C, S8A--C](#sup1){ref-type="supplementary-material"}). Δ*AMT2-5* and point mutation (DPPW to APPA, *AMT1*-APPA) cells ([Supplementary Figure S9A--C](#sup1){ref-type="supplementary-material"}) were generated using the same strategy.

We initially introduced the hemagglutinin (HA) tag to the N-terminus of the endogenous *AMT1* gene, but failed to detect any immunofluorescence signal, probably due to the low expression level ([@B31]). Instead, we generated the *AMT1* overexpression (OE) construct (AMT1-NHA-OE), by placing *AMT1* ORF, with an N-terminal HA-tag under the cadmium-inducible *MTT1* ([Supplementary Figure S5A, B](#sup1){ref-type="supplementary-material"}). The AMT1-NHA-OE construct was transformed into SB210 cells and selected in increasing concentration of Paromomycin to generate a somatic AMT1-overexpression strain or was transformed into mating pairs of SB210 and CU428 to generate a germline AMT1-overexpression strain.

To generate the *AMT1* rescue (*AMT1*-RS) construct, *AMT1* ORF and its flanking regions were cloned and the *bsr2* cassette was inserted into the 5′ UTR ([@B32]) ([Supplementary Figure S7A](#sup1){ref-type="supplementary-material"}). The *AMT1*-RS construct was transformed into Δ*AMT1* cells and selected by increasing the concentration of blasticidin S ([Supplementary Figure S7B](#sup1){ref-type="supplementary-material"}).

To generate the *RAB46* knockdown (*RAB46*-KD) construct ([@B33],[@B34]), a fragment containing 203bp *RAB46* CDS was inserted in opposite orientations downstream of the cadmium-inducible *MTT1* promoter, to produce hairpin RNA for RNAi ([Supplementary Figure S16A](#sup1){ref-type="supplementary-material"}). The *RAB46*-KD construct was transformed into WT cells and selected in increasing concentration of paromomycin ([Supplementary Figure S16B](#sup1){ref-type="supplementary-material"}). Cells were treated with 4 μg/ml CdCl~2~ for 24 h to induce the large contractile vacuole phenotype.

Phylogenetic analysis {#SEC2-3}
---------------------

The AMTs 1*--*7 amino acid sequences (gi numbers are listed in [Supplementary Table S9](#sup1){ref-type="supplementary-material"}) were queried against the NCBI nr database using PSI-BLAST ([@B35]*--*[@B37]) (maximum *E*-value = 1e--4). Retrieved hits were collapsed using CD-HIT ([@B38]) (-c 0.97) to remove redundant sequences. Only sequences corresponding to the taxa in Figure [1A](#F1){ref-type="fig"} were retained. Sequences were aligned using the MUSCLE program ([@B39],[@B40]). A Phylogenetic tree was obtained using the approximate maximum-likelihood method implemented in the FastTree 2.1 program under default parameters ([@B41]). All protein sequences used for phylogenetic analysis are listed in [Supplementary Table S9](#sup1){ref-type="supplementary-material"}.

Immunofluorescence staining {#SEC2-4}
---------------------------

Immunofluorescence (IF) staining experiments followed previously described procedures ([@B19],[@B42]). For the single antibody staining, the primary antibodies were α -6mA (Synaptic Systems, 202003, 1:2000) ([@B19]) and α -HA (Cell Signaling, \#3724, 1:200) and the secondary antibody was Goat anti-Rabbit IgG (H+L) (Invitrogen, A-21428, 1:4000). For the co-staining, cells were first incubated with α -HA (Covance, MMS-101P, 1:500, mouse) and its secondary antibody (goat anti-mouse IgG (H+L), Alexa Fluor 555, Invitrogen, A-21127, 1:4000). After crosslink by 3% PFA, α -6mA (Synaptic Systems, 202003, 1:2000) and its secondary antibody (goat anti-rabbit IgG (H+L), Alexa Fluor 488, Invitrogen, A-11008, 1:4000) were used. Digital images were collected using an Olympus BX43 microscope with an Olympus DP72 camera.

Preparation of *Tetrahymena* DNA and RNA samples {#SEC2-5}
------------------------------------------------

Genomic DNA was collected from vegetative *Tetrahymena* log-phase cells (∼2 × 10^5^ cells/ml) using Wizard^®^ Genomic DNA Purification Kit (Promega, A1120). RNA samples were extracted from vegetative log-phase cells (∼2 × 10^5^ cells/ml) by the RNeasy Plus Mini kit (Qiagen, 74134). The quality and concentration of DNA and RNA samples were analyzed by agarose gel electrophoresis and Qubit^®^3.0 Fluorometer (Thermo Fisher Scientific).

UHPLC--QQQ--MS/MS Analysis {#SEC2-6}
--------------------------

500 ng genomic DNA of *Tetrahymena thermophila* was denatured in 20 μl of ddH~2~O at 95°C for 5 min, chilled on ice rapidly for 5 min. After cooling, genomic DNA was digested into mononucleosides using a mixture of enzymes, including DNase I (1 U, NEB, M0303L), calf intestinal phosphatase (1 U, NEB, M0290L), and snake venom phosphodiesterase I (0.005 U, Sigma, P4506), at 37°C for 12 h. Digested DNA was diluted and then purified by 0.22 μm filter (Millipore, SLGVR04NL). Samples were analyzed by ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC--QQQ--MS/MS) on an Acquity BEH C18 column (75 mm × 2.1 mm, 1.7 μm, Waters, MA, USA), using a Xevo TQ-S triple quadrupole mass spectrometer (Waters, Milford, MA, USA) ([@B16],[@B45]). The mass spectrometer was set to multiple reaction monitoring (MRM) in positive electrospray mode. The selective MRM transitions were detected under *m*/*z* 266/150 for 6mA, *m*/*z* \*/\* for 1 mA and *m*/*z* 252/136 for dA. The ratio of 6mA/A was quantified by the calibration curves of nucleoside standards running at the same time.

Phenotypic analysis of vegetative Δ*AMT1* cells {#SEC2-7}
-----------------------------------------------

To monitor the growth rate, Δ*AMT1* progeny and WT (SB210) cells were cultured in SPP medium at 30°C by starting at the concentration of 0.6--0.8 × 10^5^ cells/ml. Beckman Coulter Z2 Particle Counter was used to count the cell density at indicated time points for 32 h. Statistical analysis was performed by GraphPad Prism5 ([@B46]).

Movies of swimming cells were captured in rates of 500 frames per second (fps) using an Olympus BX53F microscope with an Olympus DP74 camera. Image processing steps were performed with ImageJ (National Institutes of Health, Bethesda, MD, USA).

For the osmotic pressure test, Δ*AMT1* and WT (SB210) cells were cultured in SPP medium (-glucose) with different concentrations of sucrose (5%, 4%, 3%, 2%, 1%, 0%) until reaching the log-phase (2--3 × 10^5^ cells/ml). The numbers of cells with or without large contractile vacuoles were then calculated.

Conjugation progress analysis and viability test {#SEC2-8}
------------------------------------------------

Starved Δ*AMT1-*1-10 and Δ*AMT1-*1-11 cells (2 × 10^5^ cells/ml) were mixed to induce conjugation. Conjugating WT cells (SB210 × CU428) were used as control setups. To monitor the progress of conjugation, cells were collected at different stages of conjugation (3, 4, 6, 10 h after mixing) and fixed with 1% PFA and 100 μg/ml DAPI.

For the viability test, individual mating pairs were isolated and placed into drops with SPP medium at 10 h post-mixing. After 48 h incubation in 96-well plates at 30°C, the number of wells with viable cells was counted. To distinguish true progeny (exconjugants) from aborted pairs (non-conjugants), viable cells were starved to induce conjugation with WT cells (SB210 or CU428 respectively). Cells that were unable to mate with two WT strains of different mating types were characterized as true conjugation progeny.

Reverse transcription polymerase chain reaction (RT-PCR) and quantitative reverse transcription PCR (qRT-PCR) {#SEC2-9}
-------------------------------------------------------------------------------------------------------------

Total RNA after DNase treatment (Invitrogen, AM1907) was reverse-transcribed using an oligo-dT primer and M-MLV Reverse Transcriptase (Invitrogen, 28025013). RT-PCR was performed by using Premix Taq (TaKaRa, RR901A). The housekeeping gene *JMJ1* (TTHERM_00185640) was used for loading control and normalization. For qRT-PCR analysis of *AMT1* expression levels in growing, starved, and conjugating cells, the housekeeping gene *RPL5* (TTHERM_00736480) was used for loading control and normalization. All PCR primers are listed in [Supplementary Table S8](#sup1){ref-type="supplementary-material"}.

*Dpn*I/*Dpn*II digestion and quantitative PCR (qPCR) analysis {#SEC2-10}
-------------------------------------------------------------

*Dpn*I/*Dpn*II digestion experiment followed previously described procedures ([@B19]). *Dpn*I/*Dpn*II digested and non-digested DNA (4 ng) were loaded into the qPCR analysis using EvaGreen Express 2 × qPCR MasterMix-Low ROX (Abm, MasterMix-LR). Primers flanking selected GATC sites are listed in [Supplementary Table S6](#sup1){ref-type="supplementary-material"}. Primers in the CDS of *JMJ1* (TTHERM_00185640) were used as internal controls. The methylation level (6mA/A) is reflected by fold difference between *Dpn*I- and *Dpn*II-digested samples (ΔΔCt = ΔCt*~Dpn~*~I~ -- ΔCt*~Dpn~*~II~). ΔCt*~Dpn~*~I~ and ΔCt*~Dpn~*~II~ were normalized respectively between digested and undigested samples (ΔCt*~Dpn~*~I~ = Ct*~Dpn~*~I~ -- Ct~undigested~ and ΔCt*~Dpn~*~II~ = Ct*~Dpn~*~II~ -- Ct~undigested~). As *Dpn*I and *Dpn*II cut methylated and unmethylated GATC sequences respectively, the following results are expected. For highly methylated sites, the methylation level (6mA/A) should be larger than zero in WT and *AMT1*-RS cells, but below zero in Δ*AMT1* and *AMT1*-APPA cells. For unmethylated sites, the methylation level (6mA/A) should be substantially below zero in all four strains.

Nuclei purification and MNase sequencing analysis {#SEC2-11}
-------------------------------------------------

Nuclei purification was carried out following established protocols ([@B47]). Approximately 5 × 10^7^ purified MACs from WT and Δ*AMT1* cells were digested by Micrococcal Nuclease (400 U/ml MNase, NEB, M0247S) at 25°C for 15 min and mono-nucleosome-sized DNA was collected by phenol--chloroform extraction for sequencing.

Sequencing reads were mapped to the latest MAC genome assembly in the *Tetrahymena* genome database (TGD) (<http://ciliate.org>) ([@B48],[@B49]). The mapping results were visualized using GBrowse 2.0 ([@B50]). Only mono-nucleosome-sized fragments (120--260 bp) were analyzed. To calculate nucleosome distribution around TSS and the distance between 6mA sites and nucleosomes dyads, a dyad was defined as the midpoint of a fragment. Nucleosome frequency was counted by dyads accumulated in every base from 1000-nt upstream to 2000-nt downstream TSS. Nucleosomes were called using the NucPosSimulator ([@B51]) which identifies non-overlapping nucleosomes using fragment centers. The degree of translational positioning for each called nucleosome was described previously, defined as the number of fragment centers within ±20 bp of the called nucleosome dyad, relative to the number of all fragment centers within the 147 bp called nucleosome footprint ([@B52]). +1 to +5 nucleosomes with positioning degree ≥0.7 were selected according to their distance to TSS. 6mA between dyads was defined as all 6mA sites between dyads of nucleosome *N* and nucleosome (*N* + 1).

SMRT sequencing and data analysis {#SEC2-12}
---------------------------------

Genomic DNA prepared for SMRT sequencing libraries was extracted from WT (SB210) and Δ*AMT1* cells using Wizard® Genomic DNA Purification Kit (Promega, A1120), and sequencing was carried out by Novogene Co. Ltd (Beijing, China). Even though SMRT sequencing does not discriminate 6mA versus 1mA, we could call 6mA with confidence from SMRT sequencing results as 1mA was not detected in the *Tetrahymena* genome by mass spectrometry ([Supplementary Figure S3A--C](#sup1){ref-type="supplementary-material"}).

The latest SB210 MAC genome downloaded from TGD (<http://ciliate.org>) was used as a reference for reads mapping. 6mA was identified using the Base Modification and Motif Analysis protocol with default parameters in the SMRT link v5.10 (Pacific Biosciences). Considering the different sequencing depths between SB210 and Δ*AMT1*, all data were normalized to 100× while using strict cut-off (Qv \>30 and coverage \>25×) to filter out unauthentic modifications.

The two longest chromosomes (scf_8254667 and scf_8254697) were used for SMRT Circular Consensus Sequences (CCS) analysis. The single molecules were extracted from the raw sequencing data to calculate the IPD ratio of every base in both strands by customized Perl scripts.

To calculate 6mA density across scaffolds, the MAC scaffolds were mapped onto MIC chromosomes using NUCmer ([@B53]). Note that five scaffolds (scf_8255058, scf_8255661, scf_8255483, scf_8255586, scf_8255776) were unmapped in MIC, scaffolds without 6mA and scf_8254915 with extremely high 6mA density were also removed from the analysis. Smooth curves were plotted by ggplot2 in R ([@B54]).

For composite analysis and motif identification, 6mA was divided into groups based on their methylation level (low 10--20%, intermediate 20--80%, high 80--100%) or motifs (symmetric/asymmetric/non-AT). The number and percentage of sites of different 6mA groups were calculated by customized Perl scripts and plotted using GraphPad Prism 6 ([@B46]).

The genome-wide distribution of 6mA groups on scaffolds was counted by customized Perl scripts and the 6mA density was calculated as the number of methylated adenine sites divided by the total number of adenine sites (6mA/A) in each bin (bin size = 1 kb). The circle diagrams were generated using circlize 0.4.4 ([@B55]). Among these, the longest scaffold (scf_8254803) was shown individually.

For analysis of 6mA, H2A.Z and H3K4me3 distribution among genes, 15 841 well-modeled genes (13 854 of which are longer than 1 kb) that are strongly supported by deep RNA-seq sequencing results were selected ([@B52],[@B56],[@B57]). The gene body length was scaled to 1 unit and one-unit length was extended to each side. Customized Perl scripts were used for locus statistic (bin size = 0.05). To calculate distribution of these marks around the transcription start sites (TSS), the numbers of 6mA sites and midpoints of ChIP-Seq fragments were accumulated in every base from 1000-nt upstream to 2000-nt downstream TSS. The 6mA amount was defined as the number of methylated adenine sites combined with their methylation level.

The correlation matrix of H2A.Z, H3K4me3 and 6mA frequency was accomplished by corrplot ([@B58]), of which H2A.Z ([@B19]) and H3K4me3 were defined as midpoints of ChIP fragments accumulated in the 1 kb downstream of TSS.

To identify conserved motifs around the methylated adenines, sequences between 20-nt upstream and 20-nt downstream of 6mA sites were extracted. Local motifs nearby 6mA were illustrated by WebLogo3 ([@B59]) and GraphPad Prism 6.

To determine the correlation between changes in the number and methylation level of 6mA sites and gene expression, one-factor analysis of variance (one-way ANOVA), one sample t-test and independent sample *t*-test were all carried out by SPSS v. 22.0 ([@B60]).

To validate the dramatic change in knockout cells, we generated another Δ*AMT1* strain and subjected it to SMRT sequencing. The two strains shared 69 154 methylated adenine sites, corresponding to ∼50% overlap ([Supplementary Figure S17A](#sup1){ref-type="supplementary-material"}). More strikingly, a similar pattern of change (preferential loss of symmetric, highly methylated 6mA in the genic region) was observed in this independently generated strain ([Supplementary Figure S17B, C](#sup1){ref-type="supplementary-material"}), indicating that AMT1 indeed modulates genome-wide 6mA distribution.

RNA sequencing and data analysis {#SEC2-13}
--------------------------------

A total of twelve RNA samples of *T. thermophila* were sequenced, three replicates each for WT (SB210), *AMT1*-RS (*AMT1*-RS-14 and *AMT1*-RS-17) and Δ*AMT1* respectively. After trimming sequencing adapters and filtering low quality reads according to Trimmomatic ([@B61]) (TruSeq3-PE.fa: 2:30:10, leading: 3, trailing: 3, sliding window: 4:15, minlen: 80), the numbers of reads mapped to the genome were determined using the HTSeq2 software ([@B62]). Stringtie 1.3.4 ([@B63]) was used for assembling potential transcripts as the reference, and featureCounts ([@B64]) was implemented for counting reads to genomic features with the assembled transcripts as reference. Effective expression levels (FPKM \> 1) were calculated based on RNA-Seq coverage of these strains for counting the Pearson\'s correlation coefficients in gene expression with DEsq2 ([@B65]). Differentially expressed genes (DEGs) were also identified by DEsq2 (log~2~FoldChange \> 1 or \< -1, *P* \< 0.05). The selected genes were annotated using Interproscan 5.29 ([@B66]) and Gene Ontology (GO) analysis was performed by WEGO ([@B67]). Pathway analysis of DEGs was carried out on the KEEG web server (<https://www.genome.jp/kegg/pathway.html>). RNA-Seq data for starved cells were acquired from Feng *et al.* ([@B68]).

RESULTS {#SEC3}
=======

DNA 6mA in *Tetrahymena* mainly depends on *AMT1* {#SEC3-1}
-------------------------------------------------

We identified in the genome of *Tetrahymena thermophila* seven genes with strong homology to the MT-A70 domain of methyltransferases (MTases), and named them [a]{.ul}denine [MT]{.ul}ase 1--7 (*AMTs 1--7*) (Figure [1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"}; [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). AMT1 belongs to a distinct eukaryotic subclade, with orthologues widely distributed in protists and basal fungi, but missing in animals, plants, and true fungi. AMT2 and AMT5 are grouped into another subclade with more limited distribution in protists. AMT3 is the METTL14 orthologue, while AMT4, with the conserved N-terminal CCCH domain, is the *Tetrahymena* orthologue of METTL3. AMT6 and AMT7 form a divergent subclade; the phylogenetic distribution of their orthologues mirrors that of AMT1. *Tetrahymena* AMTs 1--4, but not 5--7, have the 6mA MTase signature motif (\[DNSH\]PP\[YFW\]) required for substrate recognition and catalytic activity ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) ([@B22],[@B69]). None of them are METTL4 homologues, which are represented by the putative DNA MTase DAMT-1 in *Caenorhabditis elegans* ([@B8]), but are not found in any protists.

To determine whether any AMTs are responsible for DNA 6mA in *Tetrahymena*, we generated knockout strains deleting each of *AMT*s 1--5, mainly focusing on genes with potential catalytic activity. Immunofluorescence staining showed that compared with wild-type (WT) cells, DNA 6mA levels in the macronucleus (MAC) of growing cells were greatly reduced in Δ*AMT1* cells, but not in *AMTs 2--5* knockout cells (Figures [2A](#F2){ref-type="fig"}, [B](#F2){ref-type="fig"}, S2A--C). This was corroborated by mass spectrometry analysis, showing that global DNA 6mA levels in Δ*AMT1* cells were reduced to about 30%--40% of WT levels (Figures [2B](#F2){ref-type="fig"}, [C](#F2){ref-type="fig"}, S2D, S3A--C). No significant change in RNA m6A levels was observed in Δ*AMT1* cells ([Supplementary Figure S3D](#sup1){ref-type="supplementary-material"}), indicating that DNA is the specific substrate for AMT1, consistent with a recently published finding that AMT1 is selective for DNA over RNA *in vitro* ([@B75]). We therefore focused our analysis on AMT1, the main DNA 6mA MTase in *Tetrahymena*.

![Germline knockout of *AMT1* (Δ*AMT1*) dramatically reduced the DNA 6mA level. (**A**) Immunofluorescence (IF) staining of DNA 6mA in logarithmically growing WT and Δ*AMT1* cells. Note the absence of 6mA signals in the MIC (arrowheads). (**B**) Statistical analysis of 6mA IF signal intensity in A. Cell images were randomly selected (WT: *n* = 263, Δ*AMT1*: *n* = 450) and processed by ImageJ. Data are presented as box plots (from top to bottom: max, first quartile, median, third quartile, and min). Student\'s *t*-test was performed. \*\*\**P* \< 0.001. (**C**) Mass spectrometry analysis of 6mA, performed on five biological replicates for WT and 39 for Δ*AMT1*. Data are presented as box plots. Student\'s *t*-test was performed. \*\*\**P* \< 0.001. (**D**) Expression profile of *AMT1* during growth (mid-log phase, ∼3.5 × 10^5^ cells/ml), starvation (15 h after starvation) and conjugation (4 h post-mixing). Expression levels are represented by normalized RNA-seq reads numbers (<http://tfgd.ihb.ac.cn/>) ([@B88]), microarray signals ([@B31]) and quantitative RT-PCR data. All expression values (in logarithm scale) were compared with values during starvation (set at 0). (**E**) IF staining of DNA 6mA in conjugating WT and Δ*AMT1* cells. Nuclear events are used to ascertain conjugation stages (see schematics on the left). The new MAC is outlined (dotted circles). Note that *de novo* occurrence of 6mA in the new MAC was dramatically reduced in Δ*AMT1* cells. (**F**) IF staining of AMT1 in growing cells. AMT1 was HA-tagged at the N-terminus (HA-AMT1) and over-expressed under the control of the *MTT1* promoter. After induction by cadmium chloride (1.5μg/ml, 30min), HA-AMT1 was detected by an α-HA antibody. Note the absence of AMT1 signals in the MIC (arrowheads). (**G**) IF staining of AMT1 in conjugating cells. Nuclear events are used to ascertain conjugation stages (see schematics on the left). Note that AMT1 signals appeared in the new MAC (dotted circles), before buildup of 6mA signals.](gkz1053fig2){#F2}

*AMT1* was expressed at high levels during growth and at low levels during starvation (Figure [2D](#F2){ref-type="fig"}). *AMT1* expression levels increased dramatically during conjugation, the sexual reproduction stage of the *Tetrahymena* life cycle (Figure [2D](#F2){ref-type="fig"}). Consistent with this expression profile, we detected abundant 6mA in WT cells during conjugation (Figure [2E](#F2){ref-type="fig"}) as well as during growth (Figure [2A](#F2){ref-type="fig"}). 6mA was exclusively detected in the parental MAC during early conjugation, while it was established *de novo* in the new MAC at late conjugation (Figure [2E](#F2){ref-type="fig"}). In comparison, 6mA signals were markedly lower in the parental MAC during early conjugation and in the new MAC during late conjugation in Δ*AMT1* cells (Figure [2E](#F2){ref-type="fig"}, S4). Taken together, these results strongly argue that DNA 6mA levels in *Tetrahymena* are mainly dependent on *AMT1* throughout its life cycle. Our conclusion is consistent with Beh et al. identifying AMT1 as a major source of the DNA MTase activity in *Tetrahymena* (referred to as *MTA1* therein) ([@B75]), but directly contradicts another publication by Luo *et al.* claiming that DNA 6mA levels in *Tetrahymena* are mainly dependent on *AMT2* (referred to as *TAMT1* therein) ([@B70]).

We next analyzed the cellular localization of AMT1 by tracking an ectopically expressed version (AMT1-NHA-OE). In growing cells, AMT1 was detected only in the MAC but not in the micronucleus (MIC) (Figure [2F](#F2){ref-type="fig"}, S5A--B), which is consistent with the exclusive presence of 6mA in the MAC (Figure [2A](#F2){ref-type="fig"}). During conjugation, AMT1 was detected in the parental MAC at early time points and in the new MAC at late time points (Figure [2G](#F2){ref-type="fig"}). This pattern is again consistent with the distribution of 6mA at different developmental stages (Figure [2E](#F2){ref-type="fig"}).

Defects in growth and development of Δ*AMT1* cells {#SEC3-2}
--------------------------------------------------

Deleting *AMT1* severely impaired cell growth, with the doubling time increased to ∼22.8 h (versus ∼5.1 h in WT cells) (Figure [3A](#F3){ref-type="fig"}). Δ*AMT1* cells swam very slowly: instead of the rapid spiraling movement typical of WT cells, the knockout cells showed dramatically reduced rotational and translational speeds (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}). We also noticed that many knockout cells contained an abnormally large contractile vacuole (Figure [3D](#F3){ref-type="fig"}), which took much longer to complete a systole/diastole cycle for water expulsion (Supplemental video). As expected, far fewer cells with an abnormally large contractile vacuole were found when cultured in hypertonic media, which eliminates the need for water expulsion ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}).

![Growth and development were severely impaired in AMT1 loss-of-function mutants. (**A**) Growth rates of WT (SB210), Δ*AMT1*, *AMT1*-APPA and *AMT1*-rescued cells (*AMT1*-RS). Cells were enumerated using a Coulter counter at the indicated time points. Doubling time (h) were calculated based on the log-phase data. (**B**) Trajectory analysis of the swimming ability. Swimming paths of indicated cells in half a second were recorded and converted to illustrations by Image J. Δ*AMT1* and *AMT1*-APPA cells swam much slower than WT cells. The swimming ability was restored in *AMT1*-RS cells. (**C**) Quantification of the translational swimming velocity. All values are normalized with that of WT cells. Data are presented as mean ± standard deviations. Student\'s *t*-test was performed. \*\*\**P* \< 0.001; ns: not significant (*P* \> 0.05); compared with WT, unless indicated otherwise. (**D**) Contractile vacuoles (CVs) observed by phase-contrast microscopy. Abnormal CVs (red arrowheads) were observed in a large portion of Δ*AMT1* and *AMT1*-APPA cells, but not in WT and *AMT1*-RS cells. (**E**) IF staining of 6mA in WT, Δ*AMT1*, *AMT1*-APPA and *AMT1*-RS cells. Note the absence of 6mA signal in the MIC (white arrowheads). (**F**) Mass spectrometry analysis of 6mA in WT, Δ*AMT1*, *AMT1*-APPA and *AMT1*-RS cells (two independent strains). Data are presented as mean ± standard deviations. Student\'s *t*-test was performed. \*\*\**P* \< 0.001; ns: not significant (*P* \> 0.05); compared with WT, unless indicated otherwise. (**G**) Correlations in gene expression profiles. Pearson\'s correlation coefficients (PCC) were calculated for pair-wise comparison and represented by the color scale. Cluster analysis, based on PCC, is shown on the left. Note the similarities between the gene expression profiles of WT and *AMT1*-rescued cells (*AMT1*-RS-14 and *AMT1*-RS-17) and their distinction from that of Δ*AMT1* cells. (**H**) Conjugation progress (h) of WT (SB210 × CU428) and Δ*AMT1* (1--10 × 1--11) cells. Cells at each time point (*n* \> 200) were classified into different developmental stages by their nuclear morphology: pre-meiosis (E1), meiosis (E2), mitosis (M), new MAC development (L1) and pair separation (L2) ([@B89]).](gkz1053fig3){#F3}

To test whether the aforementioned phenotypes were solely attributable to the lack of *AMT1*, we transformed Δ*AMT1* cells with a DNA fragment containing the WT *AMT1* gene ([Supplementary Figure S7A, B](#sup1){ref-type="supplementary-material"}). RT-PCR and qRT-PCR confirmed that *AMT1* mRNA expression was restored to WT levels in rescued (*AMT1*-RS) cells ([Supplementary Figure S8A, B](#sup1){ref-type="supplementary-material"}). Immunofluorescence staining showed that 6mA levels in rescued cells were comparable to WT levels (Figures [3E](#F3){ref-type="fig"}, S8C); this was further confirmed by mass spectrometry analysis (Figure [3F](#F3){ref-type="fig"}). Remarkably, restoring *AMT1* alone was sufficient to rescue the aforementioned defects of Δ*AMT1* cells: both slow growth (Figure [3A](#F3){ref-type="fig"}) and poor swimming (Figure [3B](#F3){ref-type="fig"}, C) were rectified, abnormally large contractile vacuoles eliminated, and the normal systole/diastole cycle restored (Supplemental video). RNA-seq analysis further confirmed that the transcription profile in rescued cells had been largely restored to that of WT cells (Figure [3G](#F3){ref-type="fig"}).

To determine whether the MTase activity of AMT1 underpins its functions, we mutated the conserved DPPW motif to APPA ([Supplementary Figure S9A--C](#sup1){ref-type="supplementary-material"}). The *AMT1* APPA mutant phenocopied Δ*AMT1* cells: it had reduced 6mA level, slow growth, poor swimming, and large contractile vacuoles (Figure [3A](#F3){ref-type="fig"}--[F](#F3){ref-type="fig"}), demonstrating that AMT1 catalyzes DNA 6mA, which in turn is required for normal cell growth and development. Intriguingly, the *AMT1* mRNA expression level in *AMT1*-APPA cells was lower than that in WT cells ([Supplementary Figure S8B](#sup1){ref-type="supplementary-material"}). A likely scenario is that *AMT1* expression is promoted by DNA 6mA levels, and is thus dependent on the MTase activity of AMT1. This scenario is consistent with high levels of 6mA sites on the gene body of *AMT1* (14.52, compared with 9.90 for genes on average).

Functions of AMT1 in conjugation were investigated by crossing two germline knockout cells. Conjugation progress was poorly synchronized and suffered major delays at key stages, including cell pairing, meiotic MIC elongation, and new MAC formation (Figure [3H](#F3){ref-type="fig"}). Many cells aborted conjugation, likely due to defective meiosis and gametogenesis, with only a small percentage reaching the final developmental stage and giving rise to viable conjugation progeny (Δ*AMT1* 6.3% versus WT 92.4%). These strong conjugation phenotypes in Δ*AMT1* cells are consistent with high expression levels of *AMT1* during conjugation (Figure [2G](#F2){ref-type="fig"}), underscoring the functional significance of AMT1.

Collectively, our results directly link *AMT1* loss-of-function to severe defects with high fitness cost, which is potentially mediated by the transcriptional effect of AMT1-catalyzed 6mA.

AMT1 promotes 6mA with high methylation levels {#SEC3-3}
----------------------------------------------

We next performed Single Molecule, Real-Time (SMRT) sequencing of genomic DNA, generating 1 684 630 and 1 851 283 reads for WT and Δ*AMT1* cells, corresponding to 137× and 160× average coverage of the *Tetrahymena* MAC genome ([Supplementary Figure S10A, Table S2](#sup1){ref-type="supplementary-material"}). We focused our analysis on 431 346 and 123 935 6mA sites called with high confidence (normalized coverage \> 25×, Qv \> 30), representing 0.54% and 0.16% of the total adenines in WT and Δ*AMT1* cells (Figure [4A](#F4){ref-type="fig"}; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). We calculated 6mA density across the genome, which was dramatically and evenly reduced in Δ*AMT1* relative to WT cells (Figures [4A](#F4){ref-type="fig"}, S10B). Consistent with the immunofluorescence staining and mass spectrometry results (Figure [2B](#F2){ref-type="fig"}, C), the SMRT sequencing result corroborates our conclusion of global 6mA reduction upon *AMT1* loss.

![Deletion of *AMT1* affected the genome-wide distribution of 6mA. (**A**) 6mA density (6mA/A) in WT (blue) and Δ*AMT1* cells (red), across the assembled *Tetrahymena* MAC genome, which are concatenated according to their positions in the MIC chromosomes. (**B**) Classification of 6mA sites according to their methylation levels (left half) and symmetry (right half), in WT (blue) and Δ*AMT1* cells (red). The left and right panels represent percentage (a particular class of 6mA/all 6mA) and the site numbers for the classes, respectively. See [Supplementary Table S3](#sup1){ref-type="supplementary-material"} for details. (**C**) Normalized 6mA distribution on scaffold_8254803 (the longest in the *Tetrahymena* MAC genome assembly) in WT and Δ*AMT1* cells. Classification of 6mA sites are the same as in (B). (**D**) Sequence logos for 6mA sites (at position 0) in WT and Δ*AMT1* cells. (**E**) Relative distribution of 6mA in ApN (ApA/ApT/ApG/ApC) dinucleotides in WT (blue) and Δ*AMT1* cells (red). Note the even distribution of 6mA on all four ApN dinucleotides in Δ*AMT1* cells. (**F**) Density plot of 6mA distribution, according to methylation levels on Watson (x-axes) or Crick strands (y-axes) in WT (left panel) and Δ*AMT1* cells (right panel). (**G**) Area-proportional Venn diagram representing highly methylated 6mA and symmetrically methylated 6mA in WT cells. (**H**) Relationship between methylation levels (x-axis) and proportion of symmetric 6mA sites (y-axis: symmetric 6mA/total 6mA) in WT (blue) and Δ*AMT1* cells (red). The linear regression trendlines and 95% confidence intervals (very narrow for Δ*AMT1* cells) are shown. (**I**) Area-proportional Venn diagram representing symmetrically methylated AT sites identified in the ensemble and 6mA-containing AT sites in single molecules. The analysis was limited to the two longest chromosomes in *Tetrahymena* (scf_8254667 and scf_8254697). (**J**) Different methylation states revealed by SMRT CCS. IPD ratios were calculated for A's in symmetrically methylated AT sites (the intersection in (I)) of every single molecule. In the scatterplot, the strand-specific IPD ratios (log~2~ transformed) is explicitly denoted in the x- (Watson strand) and y-axes (Crick strand). Note the four distinct clusters in the plot representing different methylation states: The cluster near the origin represents the unmethylated state (IPD ratios≈1); the cluster in the upper-right corner represents the full methylation state (IPD ratios≈4 for both Watson and Crick strands); two other clusters represent the hemi-methylation state (IPD ratios ≈ 4 for either Watson or Crick strand). (**K**) Four single molecules representing different methylation states for the same AT site (scf_8254697: 1 830 057--1 830 062). For each DNA molecule, the mean IPD ratios and their dispersions for Watson and Crick strands are plotted for the 6-bp region containing the AT site.](gkz1053fig4){#F4}

In the polyploid MAC, methylation levels varied almost continuously from saturation to depletion at different 6mA sites. We therefore distinguished 6mA sites with high (80--100%), intermediate (20--80%), or low methylation levels (10--20%). In WT cells, we found 37.6%, 62.3% and 0.2% of 6mA sites with high, intermediate, and low methylation levels, respectively (Figure [4B](#F4){ref-type="fig"}, left panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). We observed a downward shift of methylation levels in Δ*AMT1* cells, with 7.4%, 91.0% and 1.6% of 6mA at corresponding levels (Figure [4B](#F4){ref-type="fig"}, left panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). When the overall reduction of 6mA sites in Δ*AMT1* cells was taken into account, the reduction of highly methylated 6mA was even more conspicuous (Figure [4B](#F4){ref-type="fig"}, right panel). As illustrated in a representative genomic region, highly methylated 6mA was greatly reduced in Δ*AMT1* relative to WT cells, while 6mA with intermediate and low levels were only moderately affected (Figure [4C](#F4){ref-type="fig"}, top panel). We conclude that even though AMT1 is not the only MTase for 6mA, it strongly promotes high level methylation.

AMT1 is required for symmetric 6mA at ApT dinucleotides {#SEC3-4}
-------------------------------------------------------

In WT cells, 6mA was highly enriched at the sequence 5′-ApT-3′ (ApT: 88.2%; non-ApT: 11.8%); this effect was diminished in Δ*AMT1* cells (ApT: 47.2%, non-ApT: 52.8%) (Figure [4B](#F4){ref-type="fig"}, left panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). Indeed, the AT motif was obvious in the 6mA consensus sequence of WT cells, but was obscured in Δ*AMT1* cells (Figure [4D](#F4){ref-type="fig"}). In contrast to the strong preference for the ApT dinucleotides in WT cells, 6mA was distributed with similar probabilities in all four ApN dinucleotides in Δ*AMT1* cells (Figure [4E](#F4){ref-type="fig"}; [Supplementary Table S4](#sup1){ref-type="supplementary-material"}). These results strongly suggest that AMT1 preferentially targets the AT motif.

The palindromic AT sequence can carry 6mA on the Watson strand and/or the Crick strand. In an ensemble of DNA molecules, if 6mA is found on both the Watson and the Crick strands of a particular ApT site, this site is defined as symmetrically methylated; if 6mA is only found on either the Watson strand or the Crick strand, it is asymmetrically methylated. In WT cells, 53.5% of 6mA-containing ApT sequences were symmetrically methylated (61.5% of total 6mA), while 46.5% were asymmetrically methylated (26.7% of total 6mA) (Figure [4B](#F4){ref-type="fig"}, left panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). In Δ*AMT1* cells, symmetrically methylated ApT sequences were minimal (1.5% of total 6mA), relative to 6mA at asymmetric ApT and non-ApT sites (45.6% and 52.8% of total 6mA) (Figure [4B](#F4){ref-type="fig"}, left panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). When the overall reduction of 6mA sites in the mutant was taken into account, symmetric 6mA was all but eliminated (Figure [4B](#F4){ref-type="fig"}, right panel; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). As shown in a representative genomic region, there was almost no symmetric 6mA in Δ*AMT1* cells relative to WT cells, along with moderately reduced levels of asymmetric 6mA and slightly increased levels of non-ApT 6mA (Figure [4C](#F4){ref-type="fig"}, bottom panel).

The distribution of methylated ApT sites was plotted against methylation levels on the Watson strand and the Crick Strand. In WT cells, symmetrically and asymmetrically methylated 6mA were distributed in isolated peaks, with no obvious transition between them (Figure [4F](#F4){ref-type="fig"}). Symmetrically methylated ApT sites distributed along the diagonal line, indicating that they generally have similar methylation levels between the Watson and Crick strands (Figure [4F](#F4){ref-type="fig"}). In Δ*AMT1* cells, the peak corresponding to symmetric 6mA distribution disappeared, while the asymmetric 6mA peaks shifted towards the origin point---reflecting reduced methylation levels (Figure [4F](#F4){ref-type="fig"}). Collectively, these results indicate that AMT1 is specifically required for symmetric 6mA.

Symmetric 6mA was linked to 6mA with high methylation levels. In WT cells, there was significant overlap between the two sets of 6mA (28.5% of total 6mA; representation factor: 1.2) (Figure [4G](#F4){ref-type="fig"}). We also found a strong positive correlation between methylation levels and symmetric 6mA ratios (Figure [4H](#F4){ref-type="fig"}). In Δ*AMT1* cells, highly methylated 6mA was greatly reduced, accompanied by virtual elimination of symmetric 6mA (Figure [4B](#F4){ref-type="fig"}). A parsimonious interpretation of these results is that AMT1 drives symmetric 6mA to high methylation levels.

While symmetric and asymmetric methylation are defined at the ensemble level, full methylation and hemi-methylation are defined at the single molecule level. In an individual DNA molecule, if both adenines in the palindromic ApT site are methylated, this site is in the full methylation state; if only one of the adenines is methylated, this site is the hemi-methylation state. In WT *Tetrahymena* cells, the high levels of symmetric 6mA make it likely that at least some --- if not most --- of them are in the full methylation state. Nonetheless, SMRT sequencing in continuous long read (CLR) mode, used to generate the aforementioned results, is most informative about DNA 6mA at the ensemble level, but not at the single molecule level. To address this issue, we performed SMRT sequencing of WT cells in circular consensus sequencing (CCS) mode, in which both strands of a DNA single molecule are read multiple times, generating strand-specific and highly accurate calling of 6mA.

Analysis of the SMRT CCS data showed that almost all symmetrically methylated AT sites called at the ensemble level were also called as containing 6mA at the single molecule level (Figure [4I](#F4){ref-type="fig"}). Indeed, all four possible methylation states were revealed at the single molecule level (Figure [4J](#F4){ref-type="fig"}, [K](#F4){ref-type="fig"}): The vast majority (77.3%) of symmetric methylated AT sites were found in the full methylation state, with 6mA on both strands. 10.5% were in one of the two hemi-methylation states, representing the transitory state of symmetrically methylated AT, after DNA replication splitting parental strands in the full methylation state. Another minor group (12.2%) was in the unmethylated state, revealing the presence of the alternative epigenetic state in these sites. These results strongly support the involvement of AMT1 in maintaining symmetric 6mA as an epigenetic mark, by effective conversion of the hemi-methylation state to the full methylation state, as proposed in our previous publication ([@B19]). Our hypothesis is further supported by a recent study reporting that the hemi-methylated AT, rather than the unmethylated site, is the preferred substrate for AMT1 ([@B75]).

AMT1 affects Pol II-transcribed genes {#SEC3-5}
-------------------------------------

SMRT sequencing showed that 6mA, particularly symmetric methylation at ApT, was prominently associated with RNA polymerase II (Pol II)-transcribed genes in WT cells (Figure [5A](#F5){ref-type="fig"}), consistent with our previous work ([@B19]). By contrast, a dramatic reduction was observed in Δ*AMT1* cells (Figure [5A](#F5){ref-type="fig"}). With increased sequencing coverage ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}), we identified more putative 6mA sites on Pol I- and Pol III-transcribed genes ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}). However, most are likely false positives as they differed significantly from 6mA associated with Pol II-transcribed genes in their kinetic signature, methylation levels, and sequence characteristics ([Supplementary Figure S11A--D](#sup1){ref-type="supplementary-material"}). Even if real, these 6mA sites still only occurred at near background levels.

![AMT1 affects Pol II-transcribed genes. (**A**) Distributions of 6mA, H3K4me3, H2A.Z, and nucleosomes. In this GBrowse snapshot of a representative genomic region, tracks from top to bottom are: gene models, mRNA transcripts, 6mA (WT in blue, Δ*AMT1* in red), H3K4me3 (X-ChIP coverage), dyads of nucleosomes containing H2A.Z, and dyads of nucleosomes (WT in blue, Δ*AMT1* in red). Note the biased distribution of 6mA toward the 5′ end of a long gene (TTHERM_00498010). (**B**) Validating the methylation states of 10 GATC sites by *Dpn*I/*Dpn*II digestion. The sites were selected for their location on genes transcribed by different RNA polymerases (Pol I, II and III), and their methylation levels calculated from SMRT sequencing data (H1-H4: high methylation; N1-N6: no methylation; all in WT cells). Genomic DNA was digested with *Dpn*I or *Dpn*II; qPCR was performed with primers flanking the GATC sites to quantify undigested DNA ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). Y-axis represents the ratios between the methylated and unmethylated state (Log~2~ transformed), deduced from differential digestion by *Dpn*I and *Dpn*II. See Materials and Methods for details. (**C**) Composite analysis of 6mA distribution on the gene body of WT (blue) and Δ*AMT1* cells (red). Genes are scaled to unit length and is extended to each side by unit length. Distribution frequency was calculated as '6mA amount at a certain position/total 6mA amount'. Solid lines: high methylation levels (80--100%); dashed lines: intermediate methylation levels (20--80%). Note that the remaining 6mA in Δ*AMT1* cells was similarly accumulated downstream of transcription start sites (TSS), towards the 5′ end of the gene body. (**D**) Distribution profiles of 6mA, H2A.Z, H3K4me3 on the gene body of WT cells. Genes are scaled to unit length and is extended to each side by unit length. Note that all of them were accumulated downstream of TSS, towards the 5′ end of the gene body. (**E**) Correlation matrix of H2A.Z, H3K4me3, and 6mA frequency in 1 kb of the gene body downstream of TSS. Correlation coefficients and correlation color dots are shown. (**F**) GBrowse snapshot of the *RAB46* locus (TTHERM_00209270). Tracks from top to bottom are: gene model, mRNA transcripts, 6mA (WT and Δ*AMT1* cells), and RNA-seq coverage in WT, Δ*AMT1* and *AMT1*-RS cells (two replicates, *AMT1*-RS-17 and *AMT1*-RS-14). Note that both 6mA and *RAB46* expression were eliminated in Δ*AMT1* cells. (**G**) Extraordinarily large contractile vacuoles (CV) were observed upon *RAB46* knockdown (KD). Red arrowheads: large CV; red arrows: cells with large CV.](gkz1053fig5){#F5}

Restriction enzyme digestion was employed to validate the SMRT sequencing results. We compared *Dpn*I-digested (recognizing GATC with 6mA), *Dpn*II-digested (recognizing unmethylated GATC), and undigested genomic DNA, and determined 6mA/A ratios of several GATC sites by qPCR with flanking primers (Figure [5B](#F5){ref-type="fig"}). Four symmetrically and highly methylated sites and two unmethylated sites, determined by SMRT sequencing, were selected for Pol II-transcribed genes ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). Random sites were also selected for Pol I- and Pol III-transcribed genes (two each) ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). The four methylated sites all had high 6mA/A ratios in WT and *AMT1-*rescued cells, but much reduced 6mA/A ratios in Δ*AMT1* cells and the *AMT1*-APPA mutant. The six unmethylated sites all had very low 6mA/A ratios in all four strains. This provides an independent verification of the SMRT sequencing results and the specified 6mA distribution pattern.

6mA was mapped to about 88.33% (20 973 genes, 381 027 sites) and 76.29% (18 895 genes, 94 547 sites) of Pol II-transcribed genes in WT and Δ*AMT1* cells, respectively. As reported previously ([@B19]), 6mA was preferentially localized at the gene body in WT cells (Figure [5C](#F5){ref-type="fig"}). Despite a global reduction of 6mA levels in Δ*AMT1* cells, the distribution preference was not significantly changed (*P* \> 0.05) ([Supplementary Figure S12A](#sup1){ref-type="supplementary-material"}; Table S7). Composite analysis of 6mA distribution in 13 854 well-annotated long genes (\>1 kb) revealed moderate reductions in 6mA accumulation immediately downstream of transcription start sites (TSS) in Δ*AMT1*, relative to WT cells (Figures [5C](#F5){ref-type="fig"}, S12B and C). Enrichment at the 5′ end of the gene body was observed for 6mA of high and intermediate methylation levels, but not low methylation levels (Figures [5C](#F5){ref-type="fig"}, S12B). These results are likely underpinned by recruitment of AMT1 as well as other *Tetrahymena* 6mA MTases to promoters of Pol II-transcribed genes.

The biased distribution of 6mA toward the 5′ end of the gene body is reminiscent of distribution patterns of the histone modification H3K4 methylation and the histone variant H2A.Z (Figure [5D](#F5){ref-type="fig"}), two well-established epigenetic marks associated with Pol II transcription ([@B71]). Indeed, we found strong correlations between distributions of 6mA, H3K4 methylation, and H2A.Z (Figure [5E](#F5){ref-type="fig"}). RNA-seq analysis of WT and Δ*AMT1* growing cells revealed a large number of genes differentially expressed upon *AMT1* deletion (6,047 out of 26,996 well-annotated genes), including 3,205 upregulated and 2,842 downregulated genes (*P*~adj~ \< 0.05; at least 2-fold increase or decrease) ([Supplementary Figure S13A, B](#sup1){ref-type="supplementary-material"}). Among thousands of genes differentially expressed in WT and Δ*AMT1* cells, many were associated with high levels of 6mA in WT cells, and with substantially reduced 6mA levels in Δ*AMT1* cells ([Supplementary Figure S13C](#sup1){ref-type="supplementary-material"}); these genes are potentially under direct regulation of AMT1-deposited 6mA. However, many genes with divergent 6mA levels were not differentially expressed in WT and Δ*AMT1* cells, suggesting that they may be mainly controlled by mechanisms other than 6mA, particularly H3K4 methylation and H2A.Z, which overlap with 6mA in their distributions and potentially also in their functions ([@B19]).

Gene ontology analysis of differentially expressed genes revealed many conserved pathways affected in Δ*AMT1* cells, with potential connections to its phenotypes ([Supplementary Figure S13D](#sup1){ref-type="supplementary-material"}). Here we focused on one gene, *RAB46*, encoding a Rab family GTPase involved in membrane trafficking ([@B74]). In WT cells, *RAB46* was associated with high levels of 6mA, particularly symmetric ApT methylation, which was eliminated in Δ*AMT1* cells. *RAB46* was robustly expressed in WT cells, but not expressed in Δ*AMT1* cells (Figure [5F](#F5){ref-type="fig"}). Importantly, RNAi knockdown of *RAB46* led to abnormal contractile vacuoles, phenocopying Δ*AMT1* cells (Figure [5G](#F5){ref-type="fig"}). These results link AMT1-catalyzed 6mA with *RAB46* transcription, which in turn accounts for the most dramatic phenotype of Δ*AMT1* cells.

Attenuation of strong 6mA and nucleosome positioning relative to each other in Δ*AMT1* cells {#SEC3-6}
--------------------------------------------------------------------------------------------

In WT cells, 6mA was present mostly in linker DNA (∼50 bp) between adjacent nucleosomes, mapped by micrococcal nuclease digestion ([@B19]) (Figure [6A](#F6){ref-type="fig"}). Despite dramatic reduction, 6mA was still preferentially found in linker DNA in Δ*AMT1* cells (Figure [6A](#F6){ref-type="fig"}). This is best illustrated by composite analysis of 6mA and nucleosome distributions downstream of TSS of Pol II-transcribed genes, revealing two damped oscillations with the same periodicity of ∼200 bp, but in opposite phases (Figure [6A](#F6){ref-type="fig"}). The strong anti-correlation was obvious in both WT and Δ*AMT1* cells (Figure [6A](#F6){ref-type="fig"}). Nonetheless, the amplitude (peak-to-trough distance) for both 6mA and nucleosome distributions was reduced in Δ*AMT1* relative to WT cells (Figure [6A](#F6){ref-type="fig"}). We also calculated the degree of nucleosome positioning (Figure [6B](#F6){ref-type="fig"}), measuring the dispersion of nucleosome distribution ([@B52]). This revealed a global reduction in the degree of nucleosome positioning in Δ*AMT1* relative to WT cells ([Supplementary Figure S14A--C](#sup1){ref-type="supplementary-material"}). This trend was even more accentuated for the +1, +2 and +3 nucleosomes (as part of stereotypical nucleosome arrays downstream of TSS), which, in general, were strongly positioned in WT cells, but were weakly positioned in Δ*AMT1* cells (Figures [6B](#F6){ref-type="fig"}, S14D). These results support that the chromatin landscape of the gene body---especially the strongly positioned stereotypical nucleosome arrays---is shaped by AMT1-deposited 6mA.

![Attenuation of strong 6mA and nucleosome positioning relative to each other in Δ*AMT1* cells. (**A**) Distribution profiles of 6mA (top panel) and nucleosome (bottom panel) around TSS in WT (blue) and Δ*AMT1* cells (red). (**B**) Nucleosome positioning in WT (blue) and Δ*AMT1* (red) cells. Degrees of positioning were calculated for +1, +2 and +3 nucleosomes in the gene body. See Materials and Methods for details. (**C**) 6mA distribution relative to the nucleosome dyad in WT (top panel) and Δ*AMT1* cells (bottom panel). The violin plots show the density of 6mA between neighboring nucleosome dyads, grouped by methylation levels. The box plots within represent the median and the interquartile range of each group. Red dotted lines mark the trend for 6mA with high methylation levels to be enriched in linker DNA in WT (top panel) but not Δ*AMT1* cells (bottom panel). (**D**) Dispersions of 6mA increase further downstream of TSS in Δ*AMT1* cells (right panel) but not WT cells (left panel). The violin/box plots show 6mA distribution between neighboring nucleosomes, grouped by their positions in the gene body (+1/+2, +2/+3, +3/+4, +4/+5).](gkz1053fig6){#F6}

The remaining 6mA sites in Δ*AMT1* cells, the vast majority of which were not symmetric methylated, were more dispersed relative to adjacent nucleosomes (Figure [6C](#F6){ref-type="fig"}, [D](#F6){ref-type="fig"}). In WT cells, 6mA sites were progressively enriched in linker DNA as their methylation levels increased, and highly enriched therein upon methylation saturation (Figure [6C](#F6){ref-type="fig"}, top panel). In Δ*AMT1* cells, many more 6mA sites were found outside linker DNA, and the dispersion did not decrease monotonically with increasing methylation levels (Figure [6C](#F6){ref-type="fig"}, bottom panel). Dispersion of 6mA sites was also prominently observed in the gene body, as the oscillation amplitudes of 6mA distribution downstream of TSS were damped much faster in Δ*AMT1* than in WT cells (Figure [6A](#F6){ref-type="fig"}, top panel). Focusing on 6mA sites in between stereotypical nucleosome arrays, we found that while they were highly enriched in linker DNA in WT cells (Figure [6D](#F6){ref-type="fig"}, left panel), they were more dispersed into the nucleosomal DNA in Δ*AMT1* cells, and increasingly so further downstream of TSS (Figure [6D](#F6){ref-type="fig"}, right panel). We argue that 6mA and nucleosome distributions reinforce each other to establish the epigenetic landscape for proper expression of Pol II-transcribed genes.

DISCUSSION {#SEC4}
==========

Here we delineate the roles of the MT-A70 homologue AMT1 as an epigenetic regulator (Figure [7A](#F7){ref-type="fig"}): (i) AMT1 is the DNA 6mA methyltransferase (MTase) required for symmetric methylation at the AT motif, which constitutes the majority of 6mA in *Tetrahymena*; (ii) 6mA, especially AMT1-dependent 6mA, accumulates toward the 5′ end of Pol II-transcribed genes, orders stereotypical nucleosome arrays therein and, together with H3K4 methylation and H2A.Z, shapes the epigenetic landscape for Pol II transcription; (iii) AMT1 is required for normal growth and development while affecting expression of thousands of genes, in particular *RAB46*, which is linked to the abnormal contractile vacuole phenotype in Δ*AMT1* cells.

![AMT1 represents a new class of DNA 6mA methyltransferases and epigenetic regulators in eukaryotes. (**A**) A diagram summarizing AMT1′s roles as an epigenetic regulator. (**B**) Phyletic distribution of MT-A70 family genes (AMT1, AMT6/7, and METTL4 clades) and features of DNA methylation (high 6mA, ApT methylation, Pol II TSS association, and CpG methylation). High 6mA is defined as 6mA/A ratio higher than 0.1%. Star, triangle and square denote presence of AMT1, AMT6/7, and METTTL4 homologues in corresponding species. Solid circle, cross in circle, hollow circle, and hemi-solid circle denote presence, absence, no available data (N/A), variability/uncertainty in corresponding features of DNA methylation. See [Supplementary Table S10](#sup1){ref-type="supplementary-material"} for details.](gkz1053fig7){#F7}

This study is a logical extension of our recently published work ([@B19]), describing the first genome-wide 6mA distribution map of *Tetrahymena* and its coordination with other epigenetic players. While our manuscript was in preparation, a related study was published ([@B75]). Told from different perspectives (the present study focusing on genetics and *in vivo* cellular functions, while Beh *et al.* ([@B75]) focused on enzymology), these two studies are broadly consistent in areas where they overlap, and are complementary in many aspects in identifying AMT1, referred to by Beh *et al.* as MTA1 ([@B75]), as the major 6mA MTase in ciliates ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) (Figure [1B](#F1){ref-type="fig"}).

AMT1 represents a new family of DNA 6mA methyltransferases in eukaryotes {#SEC4-1}
------------------------------------------------------------------------

AMT1 represents a divergent subclade of eukaryotic MT-A70 MTases, which are distributed in all the super-groups of eukaryotic classification, despite evident lacunae in many branches (Figure [7B](#F7){ref-type="fig"}). AMT1 orthologues are found in all three major clades---Stramenopiles, Alveolata (containing ciliates), and Rhizaria---of the SAR super-group, though missing in Apicomplexa, a sub-group of Alveolata represented by parasitic protists such as *Plasmodium* and *Toxoplasma*. For the neighboring Archaeplastida super-group, AMT1 orthologues are widespread in green algae, but absent in plants. They are also present in some basal eukaryotes in the Excavates super-group. On the other main branches of eukaryotic divergence, AMT1 orthologues are distributed in Amoebozoa, basal (early-diverging) fungi, and some Holozoa (unicellular relatives of animals), but are conspicuously absent in true fungi (represented by budding and fission yeasts) and animals. The broad but patchy distribution of AMT1 orthologues suggests that they arose early in eukaryotic evolution, but experienced lineage-specific gene loss.

*AMT6* and *AMT7* share remarkably similar expression profiles with *AMT1* in *Tetrahymena*, with two peaks at early and late conjugation respectively ([Supplementary Figure S15](#sup1){ref-type="supplementary-material"}). More strikingly, AMT6 and AMT7 mirror the distribution of AMT1 in early-branching eukaryotes (Figure [7B](#F7){ref-type="fig"}). Only AMT1, but not AMT6 and AMT7, contains the catalytic motif (DPPW). A likely scenario is that AMT6 and AMT7 are the heterodimeric partner(s) for AMT1, analogous to the heterodimeric RNA m6A MTase subunits METTL3 (containing the catalytic site) and METTL14 (no enzymatic activity) ([@B76]). Indeed, Beh et al. identified AMT7 (referred to therein as MTA9) as an AMT1-associated protein required for its MTase activity ([@B75]). The *in vivo* functions of AMT6 and AMT7 await further investigation.

Intriguingly, the MT-A70 MTases of the METTL4 subclade, also present in a wide range of eukaryotes, show a contrasting phylogenetic distribution pattern (Figure [7B](#F7){ref-type="fig"}): they are widespread in animals and plants, they overlap with AMT1 homologues in some basal fungi and their presence in protists is obscure. The largely mutually exclusive distributions of AMT1 and METTL4 homologues coincide with the two alternative modes of DNA 6mA in eukaryotes: the former is associated with abundant 6mA in genomic DNA, symmetric methylation at ApT, and Pol II transcription; the latter corresponds to low 6mA abundance, shows no preference for the AT motif, and is generally targeted to non-genic regions. The phylogenetic distribution of METTL4 homologues bears a resemblance to that of DNA methylation at 5-methylcytosine (5mC) and its cognate DNMT MTases, which are involved in transcriptional gene silencing and heterochromatin formation ([@B77]). This suggests that METTL4-dependent 6mA may have co-evolved with DNMT-dependent 5mC, especially in animals and plants, whose genomes are generally more transcriptionally repressive and heterochromatic than those of unicellular eukaryotes ([@B78]). We argue that AMT1 homologues and METTL4 homologues represent two deep branches of eukaryotic DNA 6mA MTases, which are functionally antagonistic to each other. Their lineage-specific loss, often in a complementary pattern, may be a driver for divergent evolution of eukaryotes.

AMT1-dependent symmetric 6mA is an epigenetic mark for Pol II-transcribed genes {#SEC4-2}
-------------------------------------------------------------------------------

A strong role for AMT1-dependent 6mA in transcription regulation emerges from our results. As symmetrically and highly methylated 6mA is broadly distributed in the *Tetrahymena* genome and associated with a majority of Pol II-transcribed genes, its effects are not limited to specific pathways, as reported for animals ([@B15],[@B18]). Instead, 6mA in unicellular eukaryotes like *Tetrahymena* and *Chlamydomonas* is more likely to be integrated into transcription in general. Here we posit that symmetrically and highly methylated 6mA shapes the epigenetic landscape of transcription, analogous to, and perhaps partially redundant with, other transcription-associated epigenetic markers such as histone H3K4 methylation and histone H2A.Z variant ([@B80],[@B81]). Indeed, 6mA, H3K4 methylation and H2A.Z are strongly correlated with one another in *Tetrahymena*, with the same biased distribution towards the 5′ end of the gene body ([@B19],[@B52]). This bias further suggests that AMT1 is recruited to the promoter, similar to the H3K4 methylation-depositing MLL/SET1 complex and H2A.Z-depositing SWR1 complex ([@B82],[@B83]), supporting functional interplays in transcription regulation among one another ([@B19],[@B52]).

Distributions of 6mA and the nucleosome are mutually dependent on each other. On the one hand, AMT1 preferentially deposits 6mA in linker DNA, likely precluded by steric hindrance of the nucleosome. A similar observation is made in *Oxytricha* (another ciliate)([@B84]), in which 6mA is located in linker DNA downstream of TSS ([@B75]). On the other hand, AMT1-deposited 6mA also affects the chromatin landscape of transcription by promoting nucleosome positioning, especially for the +1, +2, and +3 nucleosomes, which are flanked by 6mA. Consistent with this, Beh *et al.* reports that the nucleosome distribution becomes fuzzier when the flanking 6mA is depleted in *Oxytricha* ([@B75]). Furthermore, *in vitro* nucleosome assembly---using the *Tetrahymena* genomic DNA with 6mA ([@B85])---can recapitulate the *in vivo* nucleosome array downstream of TSS, more so than using unmethylated DNA ([@B70]). Similarly, by comparing *in vitro* nucleosome occupancy on identical DNA sequences, with or without 6mA, Beh et al. finds that 6mA disfavors nucleosome occupancy ([@B75]). This may be attributed to intrinsic structural rigidity of DNA containing 6mA, which hinders its wrapping around the histone octamer ([@B70]). Alternatively, symmetric 6mA in linker DNA may increase the affinity for ATP-dependent chromatin remodeling complexes, or promote their activities otherwise, which are essential for ordering nucleosomes in the gene body. We envision a positive feedback loop between 6mA and nucleosome positioning for maintaining the epigenetic landscape of transcription.

Molecular mechanism for epigenetic inheritance of symmetric 6mA at ApT dinucleotides {#SEC4-3}
------------------------------------------------------------------------------------

A striking parallel can be drawn between AMT1-deposited symmetric 6mA at the AT motif in *Tetrahymena* and DNMT1-deposited symmetric 5mC at the CG motif in mammals ([@B86]), suggesting that symmetric 6mA is also maintained by a semi-conservative mechanism, on top of the specific recruitment of AMT1 to the promoter. Indeed, in asynchronously growing *Tetrahymena* cells, most symmetric 6mA sites have methylation levels near saturation; most AT sites are in the full methylation state, while only a minority is in the hemi-methylation state. These observations indicate that after replication splitting full into hemi-methylation, the latter is rapidly and efficiently converted to the former in an AMT1-dependent manner. This is corroborated by the recent finding that AMT1 preferentially methylates hemi-methylated sites ([@B75]). The two AMT1-associated proteins identified by Beh *et al.*, featuring Myb-like domains in their N-terminal regions, are potentially involved in DNA binding ([@B75]). In support, Myb binding occurs at the major groove ([@B87]) and 6mA also occurs at the major groove. Structural studies are needed to elucidate the underlying molecular mechanism for specific recognition of hemi-methylated AT and propagation of symmetric 6mA as an epigenetic mark.

Other potential regulators of 6mA in *Tetrahymena* {#SEC4-4}
--------------------------------------------------

6mA levels are reduced, but not abolished, in Δ*AMT1* cells. The complete removal of *AMT1* provides tantalizing glimpses into features of other potential 6mA regulators. By carefully checking the kinetic signatures, we are confident that the remaining 6mA in Δ*AMT1* cells are not false positives and are enzymatically catalyzed. These other DNA N^6^-adenine MTase activities are distinguished from that of AMT1 in several aspects: (i) random targeting of the ApN dinucleotides, instead of specific targeting of ApT; (ii) no symmetric methylation on the AT motif and (iii) diminished enrichment in linker DNA. On the other hand, they still preferentially deposit 6mA at the 5′ end of Pol II-transcribed genes, suggesting that the corresponding MTases, similar to AMT1, are recruited to the promoter.

AMT2 and AMT5 are distinguished by several ZZ-type zinc fingers at the C-terminus ([@B69]), which might be involved in interacting with AMT1 or binding the target DNA molecule ([@B79]). Of note, a recent study reported that somatic knockout of *AMT2* (referred to therein as *TAMT1*) suppresses 6mA levels in *Tetrahymena* ([@B70]). However, this is directly contradicted by our finding of no significant 6mA reductions in either somatic or germline knockout strains of *AMT2*. The grouping of AMT2 and AMT5 in the same subclade raised the possibility that they are functionally redundant, hence the lack of obvious phenotypes in the single knockout strain ([@B70]). AMT2 and AMT5 are likely involved in asymmetric AT methylation and non-AT methylation that are AMT1-independent. The mechanism to maintain epigenetic information carried by these 6mA sites is apparently distinct from the semi-conservative mechanism for symmetric AT methylation, and provides an intriguing direction for future studies.

DATA AVAILABILITY {#SEC5}
=================

The latest SB210 MAC genome can be found at the *Tetrahymena* genome database (TGD) (<http://ciliate.org>). Accession number for publicly available *Tetrahymena* datasets: BioProject PRJNA510457 (NCBI).
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